Keep an eye on Clorox Co. (CLX).
Typically, the stock will move higher as flu season kicks in. We expect for the stock to move higher again this year, especially with the severity of the 2022 flu season.
According to CNBC, “It’s been more than a decade – since the H1N1 swine flu pandemic – since flu hospitalization rates have been this high at this point in the season. The CDC estimates that there have been at least 880,000 illnesses, nearly 7,000 hospitalizations and 360 deaths from flu in the US this season. The first pediatric death in the country was reported this week.”
If CLX can break above resistance around $148, it could test $160. Eventually, we’d like to see the CLX stock challenge $180 again.